An Interchangeability Designation Is Not Required for a Physician to Switch a Patient to a Biosimilar Format: PDF Presented by Pfizer Posted 5/2022
Operationalizing Biosimilars Best Practices: 3 Practical Steps Toward Implementation Format: PDF Presented by Pfizer Posted 5/2022
Biosimilars in Oncology: Potential Value for Practices, Hospitals, and Healthcare Systems Format: PDF Presented by Pfizer Posted 5/2022
Important Facts Health Care Professionals Should Know About Biosimilars Format: PDF Presented by Pfizer Posted 5/2022
